News News Source Blog May 14, 2026 ASGCT and Orphan Therapeutics Accelerator Launch CGTxchange -- A First-of-Its-Kind Marketplace to Reactivate Promising Shelved Cell and Gene Therapy Programs May 14, 2026 May 14, 2026 May 11, 2026 AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases May 11, 2026 May 11, 2026 February 25, 2026 P4ML Becomes Founding Member of Orphan Therapeutics Accelerator (OTXL) to Support Broader Global Access to Ultra-Rare Disease Treatments February 25, 2026 February 25, 2026 January 7, 2026 ASGCT and Orphan Therapeutics Accelerator Launch CGTxchange - A First-of-Its-Kind Marketplace to Reactivate Promising Shelved Cell and Gene Therapy Programs January 7, 2026 January 7, 2026 December 15, 2025 Fondazione Telethon and Orphan Therapeutics Accelerator Sign Memorandum of Understanding to Pioneer Nonprofit Commercial Access Model for Ultra-Rare Disease Gene Therapy in the US December 15, 2025 December 15, 2025 August 12, 2025 Orphan Therapeutics Accelerator Launches Orphan Therapies, a Non-Profit Biotech Dedicated to Commercializing Ultra-Rare Disease Treatments August 12, 2025 August 12, 2025 May 14, 2025 Viralgen Joins Orphan Therapeutics Accelerator Clinical Development Network as a Manufacturing Partner to Advance Rare Disease Therapies May 14, 2025 May 14, 2025 April 23, 2025 Orphan Therapeutics Accelerator Announces Foundational Partnerships April 23, 2025 April 23, 2025 In the Media News Source Blog May 14, 2026 ASGCT and Orphan Therapeutics Accelerator Launch CGTxchange -- A First-of-Its-Kind Marketplace to Reactivate Promising Shelved Cell and Gene Therapy Programs May 14, 2026 May 14, 2026 May 11, 2026 AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases May 11, 2026 May 11, 2026 February 25, 2026 P4ML Becomes Founding Member of Orphan Therapeutics Accelerator (OTXL) to Support Broader Global Access to Ultra-Rare Disease Treatments February 25, 2026 February 25, 2026 January 7, 2026 ASGCT and Orphan Therapeutics Accelerator Launch CGTxchange - A First-of-Its-Kind Marketplace to Reactivate Promising Shelved Cell and Gene Therapy Programs January 7, 2026 January 7, 2026 December 15, 2025 Fondazione Telethon and Orphan Therapeutics Accelerator Sign Memorandum of Understanding to Pioneer Nonprofit Commercial Access Model for Ultra-Rare Disease Gene Therapy in the US December 15, 2025 December 15, 2025 August 12, 2025 Orphan Therapeutics Accelerator Launches Orphan Therapies, a Non-Profit Biotech Dedicated to Commercializing Ultra-Rare Disease Treatments August 12, 2025 August 12, 2025 May 14, 2025 Viralgen Joins Orphan Therapeutics Accelerator Clinical Development Network as a Manufacturing Partner to Advance Rare Disease Therapies May 14, 2025 May 14, 2025 April 23, 2025 Orphan Therapeutics Accelerator Announces Foundational Partnerships April 23, 2025 April 23, 2025
